PharmiWeb.com - Global Pharma News & Resources
17-Jan-2019

QIAGEN N.V. to Report Fourth Quarter and Full Year 2018 Results

QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the fourth quarter 2018 on Monday, February 4 at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EST). A conference call is planned for Tuesday, February 5 at 15:00 CET / 9:00 EST hosted by Peer M. Schatz, Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

Conference Call and Webcast Details
The conference call will begin at 15:00 CET / 9:00 EST on Tuesday February 5, 2019.

Interested parties may listen to the call by dialing:
+1 646 828 8195 (U.S.), +44 (0)330 336 9401 (UK), +49 (0)69 2222 10763 (Germany).
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time using the following Passcode: 966935

The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1226934&tp_key=09db1d88ba

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1226934&tp_key=09db1d88ba

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharma and biotech companies) and Academia (life sciences research).

As of September 30, 2018, QIAGEN employed approximately 4,900 people in over 35 locations worldwide.

Further information can be found at http://www.qiagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190117005326/en/

Editor Details

  • Company:
    • Business Wire
  • Website:
Last Updated: 17-Jan-2019